Thymoma-thymectomy_test | London Leading Thoracic Surgeon

Thymoma · Thymectomy · Myasthenia Gravis · London · Private

A diagnosis that stops you cold. A condition among the most curable in thoracic surgery.

Hearing the word "tumour" is frightening. But if you have been diagnosed with a thymoma — or if you have myasthenia gravis and have been told you need thymectomy — there is something important to know immediately: with the right surgery, early-stage thymoma carries a cure rate exceeding 95%.

Book a Consultation →

020 8051 7930

Mr Marco Scarci — Consultant Thoracic Surgeon London

Mr Marco Scarci FRCS · FCCP · FACS · FEBTS

>95% Cure rate, Stage I thymoma

Robotic Thymectomy available

1–2 days Hospital stay, minimally invasive

20+ Years' thoracic experience

Thymoma is highly treatable Surgery often curative at early stages Robotic & keyhole thymectomy available MG symptoms often improve after thymectomy Seen within one week

FRCS(Eng) · FCCP · FACS · FEBTS

Thymectomy for thymoma & myasthenia gravis — London

All major insurers accepted

MDT review every case

For patients and families who have just received this news

You've been told it isn't carpal tunnel. It isn't your rotator cuff. Your MRI is "normal." And you're still in pain.

If you have just been told you have a thymoma, a thymic tumour, or a mass in your anterior mediastinum, the instinct is to catastrophise. But thymoma is not like most cancers you may have heard of. It is typically slow-growing, well-defined, and in the majority of patients — particularly those with early-stage disease — surgery is curative. Most patients live full, normal lives after treatment.

This page also covers a second, closely related group of patients: those with myasthenia gravis who have been told that thymectomy may help manage their condition. About 30–50% of thymoma patients also have myasthenia gravis — and thymectomy is an established treatment for MG even without a tumour present. Both conditions are covered here, in depth.

"The majority of my thymoma patients, when they finally understand what they have been diagnosed with and what surgery involves, tell me the anticipation was far worse than the reality. Thymoma is a condition where we genuinely have excellent treatments — and excellent outcomes. My job at the first consultation is to replace fear with a plan."

This guide explains what a thymoma is, how it is classified and staged, how surgery works, what the options are, and what recovery looks like. Read it at your own pace — then reach out when you are ready.

This guide covers: Thoracic outlet syndrome diagnosis London Neurogenic TOS treatment First rib resection surgery London Scalenectomy / TOS decompression Cervical rib removal / cervical rib TOS Paget-Schroetter syndrome (venous TOS) TOS vs carpal tunnel diagnosis Brachial plexus compression symptoms Adson's test / Roos test TOS Botulinum toxin scalene injection TOS

Book a Specialist Consultation

Seen within days. No referral needed. Mr Scarci specialises in thymoma surgery and thymectomy for myasthenia gravis.

Call 020 8051 7930

Seen within one week

All major insurers accepted

Robotic thymectomy available

No GP referral required

→ Book online ✉ [email protected]

Key facts about thymoma

>95% Cure rate for Stage I thymoma after complete surgical resection

30–50% Of thymoma patients also have myasthenia gravis

Robotic Minimally invasive thymectomy — home in 1–2 days

MDT Every case reviewed at multidisciplinary team meeting

Understanding the condition

What is a thymoma — in plain English

The thymus: your immune system's early training ground

The thymus sits directly behind your breastbone in the upper chest, just in front of the heart. In childhood, it trains T-cells — the white blood cells that protect you from infection and disease. By adulthood, it has largely done its work and gradually shrinks. It is part of the anterior mediastinum — the space in the centre of the chest between the lungs.

A thymoma develops when the epithelial cells of the thymus begin to grow abnormally. Unlike many other cancers, thymoma is typically slow-growing and tends to remain encapsulated rather than spreading aggressively. This is precisely what makes early surgical removal so often permanently curative.

Thymic carcinoma is a different, rarer, more aggressive tumour requiring a multimodal treatment approach. It is important to establish which you have — which requires specialist pathological review.

Thymus gland anatomy — anterior mediastinum

Thymus position in the anterior mediastinum — accessible by minimally invasive surgery

The numbers that matter most

Thymoma staging and cure rates — what your stage means for your outlook

Thymoma is staged using the Masaoka-Koga system. The earlier the stage, the higher the cure rate — and most thymomas are discovered at early stages, often incidentally.

Stage I >95%

Fully encapsulated

Completely contained within the thymus capsule. Surgery alone is curative in the vast majority of cases.

Stage II 75–80%

Minimal invasion

Capsule or adjacent fat/pleura minimally involved. Surgery plus post-operative radiotherapy gives excellent results.

Stage III 25–50%

Local invasion

Invasion of neighbouring structures. Combined surgery, radiotherapy, and sometimes chemotherapy. Depends heavily on complete resection.

Stage IV Individualised

Spread present

Pleural, pericardial, or distant spread. Multimodal approach; outcomes vary. Full MDT review essential.

✓

Most thymomas are discovered at Stage I or II, often found incidentally on imaging. This means most patients are in the highest cure rate categories. Early surgical removal before any invasion develops is the goal — and private referral avoids the wait that can allow disease to progress.

Not sure of your stage or what it means for surgery? Mr Scarci reviews your CT, MRI, and any pathology before your consultation and explains your specific situation in full.

Book a Consultation →

WHO Classification

Types of thymoma — what your type means for treatment

Thymomas are classified from Type A (least aggressive) through B3 (more aggressive), plus the distinct and rarer thymic carcinoma. Your type influences recurrence risk and whether additional treatment is recommended after surgery.

Least aggressive

Type A

Spindle-shaped epithelial cells, few lymphocytes. Typically encapsulated, slow-growing, rarely recurs after complete surgical removal.

Excellent — surgery alone usually curative

Low risk

Type AB

Mixed cell population. Behaves similarly to Type A. Well-encapsulated and responds excellently to surgical resection.

Very good outcomes; low recurrence

Low–moderate

Type B1

Resembles normal thymic tissue with abundant lymphocytes. Low-grade with small but real recurrence risk. Surgery highly effective.

Good — long-term surveillance needed

Moderate

Type B2

More epithelial-dominant, fewer lymphocytes. Higher recurrence risk. Complete surgical excision with clear margins critical. Post-operative radiotherapy often recommended.

Complete resection + radiotherapy typical

Higher risk

Type B3

Predominantly epithelial with minimal lymphocytes. More aggressive behaviour; higher risk of local invasion. Surgery with radiotherapy and sometimes chemotherapy is standard.

Multimodal treatment usually required

Rare / aggressive

Thymic Carcinoma

A true carcinoma — distinct histological features, more aggressive, higher risk of distant spread. Requires surgery plus chemotherapy and radiotherapy. MDT input essential throughout.

Specialist MDT management; outcomes vary by resectability

How thymoma presents

Symptoms — from silent discovery to systemic effects

Many thymomas cause no symptoms at all. When they do, the presentation varies widely — which is one reason the diagnosis can be delayed or unexpected.

Incidental discovery — no symptomsUp to half of thymomas are found on imaging done for another reason — a chest X-ray, pre-operative CT, or cardiac assessment. This is an ideal outcome: early discovery before any symptoms or invasion develop.
Chest pressure or breathlessnessAs the tumour grows, it can compress nearby structures — trachea, great vessels, or lung — causing a sense of fullness, shortness of breath, or difficulty taking a full breath.
Persistent dry coughA non-productive cough without an obvious infectious cause, particularly one that doesn't respond to usual treatments, can reflect a mediastinal mass pressing on bronchial structures.
Chest pain or sternal discomfortDull aching discomfort or pressure behind the breastbone can result from the tumour pressing on surrounding structures. Often intermittent and easy to dismiss initially.
Unexplained fatigue or weight lossSystemic symptoms without a clear cause, particularly combined with any of the above, should prompt investigation including chest imaging.

The myasthenia gravis connection

In 30–50% of thymoma patients, the tumour triggers an autoimmune response affecting the neuromuscular junction — causing myasthenia gravis. MG symptoms may actually appear before the thymoma is detected, and subsequent chest imaging reveals the underlying cause.

Drooping eyelids (ptosis) — often worse towards evening
Double or blurred vision
Difficulty swallowing certain foods
Muscles that fatigue unusually quickly with repeated use
Voice changes or difficulty speaking at length
Generalised fluctuating muscle weakness

If you have myasthenia gravis, thymectomy may significantly reduce your symptoms — even if no thymoma is identified.

The primary treatment

Thymectomy surgery — removing the thymus and the tumour

Surgery is the cornerstone of thymoma treatment. Complete resection with clear margins is the single most important determinant of long-term outcome. Minimally invasive approaches have transformed what recovery looks like.

Why complete surgical resection is everything

The single most important factor in thymoma outcomes is whether the tumour is completely removed with clear surgical margins. Incomplete resection dramatically increases recurrence risk. This is why thymectomy must be performed by a thoracic surgeon with specific experience in mediastinal and thymic surgery.

Robotic and VATS thymectomy have made complete resection achievable through very small incisions for the majority of early-stage cases, transforming the patient experience without compromising the oncological quality of the operation.

Discuss surgery with Mr Scarci →

>95%Cure rate, complete resection Stage I

1–2Days hospital stay, minimally invasive

3 weeksReturn to normal activity, most patients

3DRobotic magnified visualisation available

Surgical approaches — which is right for you

Most precise

Robotic-Assisted Thymectomy

Through 3–4 incisions of 8–12mm, the surgeon operates guided by a high-definition 3D camera with magnified visualisation. The robotic platform provides articulating instruments with greater dexterity near the great vessels, pericardium, and phrenic nerve that surround the thymus — maximising precision in a complex anatomical space. Now the preferred approach for MG patients at many major UK centres.

✓ Maximum precision near critical structures · Minimal scarring · Fastest recovery

Minimally invasive

VATS Thymectomy (Keyhole)

Video-Assisted Thoracoscopic Surgery uses small incisions and a camera for the lateral chest wall approach. Well-established for appropriately selected early-stage thymomas. Offers the core benefits of minimally invasive surgery — shorter hospital stay, less pain, faster return to normal life — without the requirement for the robotic platform in straightforward cases.

Excellent for early-stage, encapsulated thymomas

Complex cases

Median Sternotomy (Open)

The traditional approach through the breastbone provides the widest exposure and remains appropriate for large, invasive, or complex tumours where complete resection requires greater access. For Stage III/IV cases or where cardiac or great vessel involvement is present, this approach delivers the surgical thoroughness these cases require.

Gold standard for complex, invasive, or large tumours

Not sure which surgical approach is right for your case? The technique depends on tumour size, stage, invasion, and overall health. Mr Scarci recommends the appropriate approach at consultation after personally reviewing your imaging.

Discuss your options →

Thymectomy for myasthenia gravis

Why removing the thymus helps myasthenia gravis

The thymus plays a central role in MG — it is involved in producing the autoantibodies that block signals between nerves and muscles. About 70% of MG patients with AChR antibodies have thymic abnormalities — hyperplasia or thymoma. Removing the thymus reduces this aberrant antibody production. A landmark 2016 randomised controlled trial established thymectomy as first-line therapy for non-thymomatous generalised MG with AChR antibodies.

70% See meaningful symptom improvement within 1–2 years

30–40% Achieve complete remission — no symptoms, no medication

2.4× More likely to achieve remission vs. medication alone

1–2 days Hospital stay, robotic approach

Who benefits most from thymectomy for MG?

Patients with AChR antibody-positive generalised MG, those with a confirmed thymoma, and those with early disease where medication has not produced satisfactory control. Age alone is not a contraindication — individual clinical assessment matters far more.

Pre-operative optimisation

Surgery can temporarily worsen MG symptoms. Pre-operative stabilisation with IVIG or plasmapheresis is used to optimise muscle strength and reduce the risk of post-operative myasthenic crisis — planned jointly between Mr Scarci and the treating neurologist.

The neurology–surgery partnership

Thymectomy for MG requires close coordination between thoracic surgeon and neurologist before, during, and after the operation. Medication management, anaesthetic planning, and post-operative monitoring are all informed by specialist neurological input throughout.

Realistic expectations — results take time

Thymectomy does not produce immediate remission. Most patients see the full benefit 1–2 years after surgery, as antibody levels gradually fall. Medication continues post-operatively and is reduced slowly by the neurologist as symptoms improve. The long-term trajectory is strongly positive for most.

Discuss thymectomy for MG →

Beyond surgery

Further treatment — when and why it is recommended

For most early-stage thymomas, surgery alone is sufficient. Additional treatment is recommended based on stage, type, and completeness of resection.

⚡

Post-operative Radiotherapy

Targeted radiation to the mediastinum is often recommended after surgery for Stage II–III thymoma, when clear margins are uncertain, or when there are features suggesting higher recurrence risk. Modern radiotherapy is precisely targeted to minimise side effects.

Typically: Stage II–III or incomplete resection

💊

Chemotherapy

Neoadjuvant chemotherapy (before surgery) can shrink larger tumours to improve resectability. Adjuvant chemotherapy may be used for Stage III/IV thymic carcinoma or highly invasive thymoma. Thymoma chemotherapy typically has fewer side effects than regimens for other cancers.

Typically: Advanced stages, thymic carcinoma, large pre-operative tumours

🔬

Immunotherapy & Clinical Trials

Checkpoint inhibitors are under investigation for thymic carcinoma and refractory thymoma. Clinical trial access through the private sector may be available for eligible patients. Mr Scarci's MDT can advise on current opportunities.

For advanced, refractory, or recurrent disease

📅

Long-term Surveillance

Thymoma can recur — sometimes years after initial treatment — making long-term CT surveillance essential. Annual imaging gradually reduced over time is the standard approach. Mr Scarci coordinates this directly with patients and communicates results personally.

Required for all patients after thymoma treatment

Why patients choose private specialist care

Expert thymoma care — without the wait that allows uncertainty to grow.

When a scan has found a mediastinal mass, the most damaging thing is not the tumour — it is weeks of not knowing what it means or what happens next.

🔬

Subspecialty mediastinal expertise

Thymectomy requires specific thoracic and mediastinal surgical experience. Mr Scarci performs this as a core part of his practice, not as an occasional unfamiliar procedure.

⚡

Seen within days, not months

A mediastinal mass requires prompt assessment. Most patients are seen within one week. Diagnosis, MDT review, and surgical planning are completed rapidly.

🤝

Full MDT review for every case

Every case is reviewed by a multidisciplinary team — thoracic surgeon, oncologist, radiologist, and pathologist — before a treatment recommendation is made. No patient is managed by a single clinician's view.

🧠

Neurology coordination for MG

For myasthenia gravis patients, thymectomy planning involves close collaboration with a specialist MG neurologist at every stage — before, during, and after surgery.

📞

Direct access to your surgeon

You speak to Mr Scarci — not a relay of messages through secretaries. Questions between appointments are answered promptly, personally, and honestly.

🛡️

Insurance navigation built in

All major insurers are accepted. Pre-authorisation and claims are managed by the team, freeing you to focus on your health and recovery rather than administrative complexity.

Your questions answered

Everything patients want to know about thymoma and thymectomy

Is thymoma really curable? What are the actual survival rates?
Yes — thymoma is highly curable, particularly at early stages. Stage I thymoma (fully encapsulated, no invasion) carries a cure rate exceeding 95% with complete surgical resection. Stage II achieves 75–80%. Even Stage III treated with combined surgery, radiotherapy, and chemotherapy achieves cure in 25–50% of patients. Thymoma is among the more treatable thoracic malignancies — the key is complete surgical resection with clear margins by an experienced thoracic surgeon.
What is the difference between thymoma and thymic carcinoma?
They are fundamentally different tumours despite sharing the same organ of origin. Thymoma arises from thymic epithelial cells and retains some characteristics of normal thymic tissue — it is typically slow-growing, usually well-encapsulated in early stages, and highly responsive to surgery. Thymic carcinoma is a true carcinoma — lacking normal thymic architecture, behaving more aggressively, more likely to invade surrounding structures and spread to distant sites, and requiring a more intensive multimodal treatment approach. Distinguishing between them requires pathological review, which is why specialist diagnosis matters before any treatment planning.
What is the difference between robotic and VATS thymectomy?
Both are minimally invasive approaches that avoid the large incision of traditional open sternotomy. VATS uses standard thoracoscopic camera and instruments through small chest incisions. Robotic thymectomy adds a robotic platform providing a 3D high-definition magnified view and articulating instruments with greater dexterity than standard thoracoscopic tools. The robotic approach is particularly advantageous near the great vessels, pericardium, and phrenic nerve surrounding the thymus — allowing more precise dissection in an anatomically complex space.
I have myasthenia gravis but no thymoma — will thymectomy help?
Thymectomy is now an evidence-based treatment for AChR antibody-positive generalised myasthenia gravis even without a detectable thymoma — established by a landmark 2016 randomised controlled trial. Around 70% of patients see meaningful improvement in symptoms and medication requirements within 1–2 years of surgery. Around 30–40% achieve complete remission. The benefit is not immediate — antibody levels fall gradually, and medication is reduced slowly by the neurologist over time. Patients with MuSK antibodies have a less certain benefit; individual assessment with the treating neurologist is essential.
How long does thymectomy recovery take?
Recovery depends on the surgical approach. Robotic or VATS thymectomy: hospital stay 1–2 days; driving and light activity by week 2; desk work by week 3; full activity by week 6. Open sternotomy: hospital 3–5 days; desk work by 4–6 weeks; full activity by 8–12 weeks. Most early-stage thymoma patients and MG patients are candidates for minimally invasive approaches and experience a recovery that is far faster than they anticipated before the consultation.
Can thymoma come back after surgery?
Recurrence is uncommon after complete surgical resection of early-stage thymoma but does occur, which is why long-term surveillance CT imaging is essential. Recurrent thymoma is usually amenable to further treatment — re-operation in selected cases, radiotherapy, or systemic chemotherapy — and the pattern of recurrence determines the best approach. Recurrence is manageable in most cases. This is why follow-up is maintained indefinitely rather than discharged at a fixed time point.
Will my insurance cover thymoma treatment?
Thymoma treatment — including imaging, biopsy, thymectomy surgery, and post-operative radiotherapy — is covered by all major UK private health insurers as a cancer treatment. Thymectomy for myasthenia gravis is also covered as a medically indicated surgical procedure. Mr Scarci's team will verify your specific policy, manage pre-authorisation, and handle insurer communication throughout your care. Self-funding is available with transparent pricing provided before any commitment.